A retrospective study of palivizumab for syncytial virus prophylaxis in children with cardiac disease
Latest Information Update: 03 Dec 2015
At a glance
- Drugs Palivizumab (Primary)
- Indications Respiratory syncytial virus infections
- Focus Therapeutic Use
- 03 Dec 2015 New trial record